A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 36/71 (2006.01) A61K 31/352 (2006.01) A61P 5/30 (2006.01) A61P 9/10 (2006.01) A61P 15/12 (2006.01) A61P 19/10 (2006.01)
Patent
CA 2321444
The invention relates to the utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament for selectively treating and/or for the prophylaxis of cardiovascular diseases, especially arteriolosclerosis, osteoporosis and climacteric symptoms, for example, for preventing or alleviating hot flashes. Virtually no uterotropic effects are observed when using said abstracts.
L'invention concerne l'utilisation d'extraits de plants d'iris, de cimicifuga racemosa et de tectorigénine comme médicament oestrogénoïde organosélectif pour le traitement sélectif et/ou la prophylaxie des maladies cardiovasculaires, notamment de l'athérosclérose, de l'ostéoporose et des symptômes climatériques, par exemple pour prévenir ou atténuer les bouffées de chaleur. Pratiquement aucun effet utérotrope n'a été observé lors de l'utilisation de ces extraits.
Christoffel Volker
Jarry Hubertus
Popp Michael
Spengler Barbara
Wuttke Wolfgang
Bionorica Arzneimittel Gmbh
Bionorica Se
Borden Ladner Gervais Llp
LandOfFree
Utilization of extracts from iris plants, cimicifuga... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Utilization of extracts from iris plants, cimicifuga..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Utilization of extracts from iris plants, cimicifuga... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1770062